Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

• Ema Mosleh,
• Stacy Snyder,
• Ningying Wu,
• Daniel N. Willis,
• Rema Malone,
• Robert J. Hayashi

Affiliations

Ema Mosleh

Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States

Stacy Snyder

Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States

Ningying Wu

Biostatistics Shared Resource, Division of Public Health Sciences and Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States

Daniel N. Willis

Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States

Rema Malone

Division of Pediatric Hematology/Oncology, St. Louis Children’s Hospital, St. Louis, MO, United States

Robert J. Hayashi

Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States